Collaboration leverages two CDx assays from Thermo Fisher to support greater access to genomic testing for cancer patients in Japan and the United States CARLSBAD, Calif. — To support emerging precision therapies and improve patient outcomes by increasing access to reliable genomic testing needed to match patients with targeted cancer treatments, Thermo Fisher Scientific today […]
PanHeme assay for blood cancers slashes wait time for results from 3-4 weeks to under 72 hours BUFFALO, N.Y. — An advanced, high-speed blood cancer test developed at Roswell Park Comprehensive Cancer Center has been licensed for commercial development by Agilent Technologies Inc., a global leader in life sciences, diagnostics and applied markets. PanHeme, an […]
Dublin, Ireland – ERS Genomics Limited (‘ERS’) completes licensing agreement with Syngene International, India’s leading Contract Research, Development and Manufacturing Organization. Syngene gains access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners. ERS Genomics, co-founded by Dr. Emmanuelle Charpentier, a recipient of […]
SAN JOSE, California — Complete Genomics, Inc., a pioneering genomic sequencing company, today announced its partnership with Integrated DNA Technologies (IDT), a global genomics solutions provider, to develop an ecosystem of advanced compatible products based on Complete Genomics’ innovative DNBSEQ™ sequencing platforms. “High-throughput sequencing is a multi-step process that demands high accuracy and performance while maintaining […]
The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting-edge science BOSTON, USA and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK), a top cancer treatment and research institution, and AstraZeneca (LSE/STO/Nasdaq: […]
SAN JOSE, California — Complete Genomics, Inc., a pioneering genomic sequencing company, today announced its partnership with Integrated DNA Technologies (IDT), a global genomics solutions provider, to develop an ecosystem of advanced compatible products based on Complete Genomics’ innovative DNBSEQ™ sequencing platforms. “High-throughput sequencing is a multi-step process that demands high accuracy and performance while maintaining an easy-to-use workflow. […]
CRISPR-Ready ioGlutamatergic NeuronsTM are first-in-class stem-cell derived human neurons containing a constitutively-expressed Cas9 nuclease for gene knockouts and CRISPR screens. New cell type creates an opportunity for research and drug discovery scientists to knockout any gene of interest in glutamatergic neurons; potential applications include studies of neurodegenerative diseases such as Parkinson’s and Huntington’s disease as well […]
Expanded footprint, new capabilities mark IDT’s entrance into CRISPR therapeutics space CORALVILLE, Iowa – Global genomics solutions provider Integrated DNA Technologies (IDT), an operating company in the Life Sciences segment of Danaher Corporation (NYSE:DHR), today announced the completion of its new Therapeutic Oligonucleotide Manufacturing facility in Coralville, Iowa. The milestone marks a significant achievement in the […]
22 years ago, Eppendorf introduced the groundbreaking automation-friendly two-component twin.tec® PCR Plates. Today, we are thrilled to announce that Eppendorf has reimagined them. Following the successful launches of Eppendorf Tubes® in the biobased generation and epT.I.P.S.® BioBased, Eppendorf is proud to introduce the twin.tec PCR Plates BioBased. These full skirted plates come with 96 wells and are available […]
Lausanne, Switzerland – Saphetor SA today announces that it is partnering with world-leading healthcare intelligence and clinical research organization ICON to develop an innovative approach to support the planning and execution of clinical trials in the precision medicine and rare diseases space. The companies are exploring how Saphetor’s variant interpretation platform VarSome.com can be further leveraged […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
